Page 4 - Best hematologist-oncologists: TOP 169 doctors

Professor Drach has performed 1,100+ oncology procedures and led the Multiple Myeloma and Malignant Lymphoma program at Vienna's University Hospital – one of Europe's largest.

• Specializes in hematologic oncology with of experience
• Former head physician at Vienna's University Hospital of Internal Medicine I
• Published 120+ scientific papers on hematology and oncology
• Board member of Austrian Society of Hematology and Oncology
• Offers second opinions and pre-surgical therapy optimization

Dr. Carmen Martínez Chamorro specializes in adult bone marrow transplants for leukemia, lymphoma, and myeloma at Quironsalud Madrid.

• Deputy Head of Hematology at Quironsalud Madrid
• Author of 20 medical articles and participant in 60 conferences
• Trained at La Princesa University Hospital in Madrid
• Recipient of the National Prize for Research in Surgery

Professor Hasan Atilla Ozkan leads the Turkish Therapeutic Apheresis Association and specializes in stem cell transplantation at VM Medical Park Pendik Hospital.

• 23 years of experience of experience in hematology and bone marrow transplantation
• Certified in autologous and allogeneic stem cell transplantation by EBMT
• Current professor at Yeditepe University Faculty of Medicine
• Recipient of the Young Researcher Award in Therapeutic Apheresis

Forbes-listed as one of Israel's best doctors – Dr. Goldstein leads Pediatric Oncology at Hadassah Medical Center.

• Specializes in pediatric hemato-oncology for over 27 years of experience
• Expert in retinoblastoma and precision medicine approaches
• Performs haploidentical bone marrow transplants for children
• Member of four international pediatric oncology associations

Dr. Osman Ilhan is a Professor of Internal Diseases. He earned his medical degree at Ankara University in 1978. He completed his specialization in Internal Diseases there in 1982. He became an Associate Professor in 1990 and a Professor in 1996.

He served as a professor at Ankara University from 1997 to 2022. He has worked at Lokman Hekim Akay Hospital since 2023. Earlier, he held roles at MD Anderson Cancer Center (1996–1997), Ankara University (1978–1983; 1988–1995), GATA (1984–1985), and Ulus Hospital (1985–1988).

Prof. Reuven Or leads the Department of Hematology and Bone Marrow Transplantation at Hadassah – a pioneer in cancer immunotherapy and cell therapy.

• specializing in bone marrow transplants and hematologic cancers
• Medical Director of Israel's National Blood Bank and Public Bone Marrow Registry
• Recipient of the prestigious Menachem Begin Prize for medical achievements
• Trained at top institutions in Italy and the US
• Published multiple research articles in medical journals

Specializes in hematologic cancers and advanced bone marrow transplants – Dr. Alemdar combines academic excellence at Akdeniz University with 20 years of experience of clinical practice.

• Board-certified in Medical Oncology with additional Internal Medicine training
• Expert in CAR T-cell therapy and haploidentical stem cell transplants
• Member of the Turkish Medical Oncology Association
• Works at JCI-accredited Medical Park Antalya Hospital Complex

1,100+ lymphoma procedures performed – Prof. Weidmann heads Hematology at Nordwest Clinic, a leading center for blood disorders.

• Specializes in both Hodgkin's and non-Hodgkin lymphoma care
• Professor with extensive academic and clinical expertise
• 36 years of experience focused on blood disorder treatments
• Leads one of Germany's top hematology departments

Assoc. Prof. Dr. Özlem Köroğlu is a specialist in Physical Medicine and Rehabilitation at Memorial Ankara Hospital (2024–present). She previously served as a faculty member at Gaziler Physical Therapy and Rehabilitation Training and Research Hospital (2016–2024). She was Chief of the Physical Medicine and Rehabilitation Clinic at Elazığ Military Hospital (2011–2015). She earned her MD in 2003 from the GATA Faculty of Medicine. She completed her PM&R residency in 2011.

Her credentials include Ministry of Health–approved certified prolotherapy training. She has taught Prolotherapy and PRP (2022) and Knee Prolotherapy and Campinject (2019). She also taught GETAT and Dextrose Prolotherapy (2018) and ISPRM Ultrasound (2009). She has additional training in musculoskeletal ultrasound, neural therapy, lumbar injections and manipulation, and botulinum toxin treatment for the spastic hand. She attended the Euro‑Mediterranean PRM School in Italy (2010). She is a member of the Turkish Society of PM&R, the Turkish Society for Research and Fight Against Rheumatism, the Association of PM&R Specialists of Türkiye, the Spinal Cord Diseases Association, and the Ankara Medical Chamber.

Dr. Hana Golan, MD, heads the Pediatric Hemato-Oncology and Bone Marrow Transplantation (BMT) Division at Sheba Medical Center. She specializes in childhood cancers, with a focus on neuroblastoma and other high-risk solid tumors.

She leads one of the region’s most advanced pediatric oncology programs. She manages complex, high-risk cases and practices at a hospital ranked in the global top 10.

She is the principal investigator of the High-Risk Neuroblastoma ESIOP protocol. She serves as an investigator in international Phase I/II trials and as the national coordinator of multicenter oncology protocols. She led the development of computerized chemotherapy protocols and patient databases to improve safety.

She earned her MD from the Technion. She completed residencies in pediatrics and pediatric hemato-oncology at Sheba. She conducted advanced research in transplantation immunology at the Weizmann Institute. She is board-certified in Pediatrics and Pediatric Hematology-Oncology. She is a Senior Lecturer at the Sackler Faculty of Medicine, Tel Aviv University. Her research focuses on cancer stem cells, targeted therapies, treatment-resistant malignancies, and cannabinoid-related oncology.

Expert in Hematology Oncology with personalized immunotherapy and high-dose chemotherapy protocols. Dr. Manuel Sureda González combines research with clinical practice at Quironsalud Torrevieja.

• Board-certified in Medical Oncology with over 76 years of experience of experience
• Specializes in autologous bone marrow transplants and high-dose chemotherapy
• Developed personalized cancer therapy using RNA microarrays and pharmacogenomics
• Member of AACR, ASCO, and ASH
• Director of Hematopoietic Progenitor Transplant Program at General Hospital of Catalonia

Dr. Abraham Avigdor, MD, is Director of the Institute of Hematology and Co‑Director of the Hematology & Bone Marrow Transplantation Division at Sheba Medical Center. He is an international leader in lymphoma, CAR‑T, and advanced hemato‑oncology with more than 35 years of experience. His clinical focus includes lymphomas, multiple myeloma, and complex blood cancers.

He is a pioneer in CAR‑T integration. He leads cellular therapy and bone marrow transplantation programs (autologous and allogeneic). He also advances stem cell therapies and precision diagnostics, including PET/CT‑based prognostics. His work includes immunotherapy and targeted regimens and the development of innovative, data‑driven protocols.

He collaborates with LYSA, EMCL, and international PET groups. He has authored more than 130 publications. Key roles include Founder and President of the Israeli Lymphoma Working Group, former Chair of the Israeli Lymphoma Study Group, and Senior Lecturer at Tel Aviv University. Education: MD, Ben‑Gurion University; residency, Sheba Medical Center; postdoctoral fellowship, Weizmann Institute. Awards include the Knesset Prize, the Israeli Ministry of Health Award, and the Sackler Prize.